Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;101:995-1001

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramanna, H.
Right arrow Articles by Robles de Medina, E. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramanna, H.
Right arrow Articles by Robles de Medina, E. O.
Related Collections
Right arrow Electrophysiology
Right arrow Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2000;101:995.)
© 2000 American Heart Association, Inc.


Clinical Investigation and Reports

Identification of the Substrate of Atrial Vulnerability in Patients With Idiopathic Atrial Fibrillation

Hemanth Ramanna, MD; Richard N. W. Hauer, MD; Fred H. M. Wittkampf, PhD; Jacques M. T. de Bakker, PhD; Eric F. D. Wever, MD; Arif Elvan, MD; Etienne O. Robles de Medina, MD

From the Heart-Lung Institute (H.R., R.N.W.H., F.H.M.W., A.E., E.O.R.d.M.), University Medical Center Utrecht, Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (J.M.T.d.B.), Utrecht, the Netherlands; and St Antonius Hospital (E.F.D.W.), Nieuwegein, the Netherlands.

Correspondence to Hemanth Ramanna, MD, Heart-Lung Institute, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.

Background—Experimental studies have shown that atrial fibrillation (AF) causes remodeling, which facilitates AF perpetuation. AF may also, however, occur in patients without remodeling and underlying structural cardiac disease. The substrate for enhanced vulnerability in these patients is unknown.

Methods and Results—We studied 43 patients without structural heart disease: 18 patients with documented sporadic paroxysmal AF and 25 control patients without AF. In each patient, a decapolar catheter was positioned against the right atrial free wall, and a quadripolar catheter was positioned in the right atrial appendage. Unipolar electrograms were recorded. Atrial vulnerability was assessed according to an increasingly aggressive stimulation protocol. Mean local fibrillatory interval (FI) was used as an index of local refractoriness. Spatial dispersion of refractoriness was assessed through the calculation of the coefficient of dispersion (CD), which was defined as the SD of mean local FI expressed as a percentage of the mean FI. In the AF group, AF was induced with a single extrastimulus in 16 of 18 patients; the CD was 5.4±2.6, and the mean FI was 164±29 ms. In the control group, AF could be induced only with more aggressive pacing in 23 of the 25 patients; the CD was 1.4±0.7 (P<0.0001), and the mean FI was 175±26 ms (NS).

Conclusions—Patients with idiopathic AF showed increased dispersion of refractoriness, which may be the substrate for the observed enhanced inducibility and spontaneous occurrence of AF.


Key Words: atrium • fibrillation • electrophysiology




This article has been cited by other articles:


Home page
EuropaceHome page
K. A. Hafid, H. C. Xin, W. Xi, Z. Q. Yan, and Y. Bo
Difference between electrical remodelling after pulmonary veins and right atrium appendage pacing
Europace, July 13, 2007; (2007) eum108v1.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 651 - 745.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246.
[Full Text] [PDF]


Home page
CirculationHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation, August 15, 2006; 114(7): e257 - e354.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Takahashi, P. Jais, M. Hocini, P. Sanders, M. Rotter, T. Rostock, L.-F. Hsu, F. Sacher, J. Clementy, and M. Haissaguerre
Shortening of Fibrillatory Cycle Length in the Pulmonary Vein During Vagal Excitation
J. Am. Coll. Cardiol., February 21, 2006; 47(4): 774 - 780.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
J. J.H. Chong, S. Kumar, L. Thomas, and S. Thomas
Supraventricular ectopy and recurrence of atrial fibrillation after electrical cardioversion.
Europace, January 1, 2006; 8(5): 341 - 344.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Firouzi, H. Ramanna, B. Kok, H. J. Jongsma, B. P.C. Koeleman, P. A. Doevendans, W. A. Groenewegen, and R. N.W. Hauer
Association of Human Connexin40 Gene Polymorphisms With Atrial Vulnerability as a Risk Factor for Idiopathic Atrial Fibrillation
Circ. Res., August 20, 2004; 95(4): e29 - e33.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. J.J.M Brundel, H. H Kampinga, and R. H Henning
Calpain inhibition prevents pacing-induced cellular remodeling in a HL-1 myocyte model for atrial fibrillation
Cardiovasc Res, June 1, 2004; 62(3): 521 - 528.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
B. Gorenek, G. Kudaiberdieva, O. Goktekin, Y. Cavusoglu, A. Birdane, A. Unalir, N. Ata, and B. Timuralp
Long-short sequence may predict immediate recurrence of atrial fibrillation after external cardioversion
Europace, January 1, 2003; 5(1): 11 - 16.
[Abstract] [PDF]


Home page
EuropaceHome page
E. R. Jessurun, J. M. T. de Bakker, N. M. van Hemel, T. Opthof, A. C. Linnenbank, P. F. H. M. van Dessel, J. J. A. M. T. Defauw, and A. B. de la Riviere
Right atrial modification of maze surgery does not affect refractoriness and conduction patterns of human lone atrial fibrillation
Europace, January 1, 2003; 5(1): 39 - 46.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
H. Morita, K. Kusano-Fukushima, S. Nagase, Y. Fujimoto, K. Hisamatsu, H. Fujio, K. Haraoka, M. Kobayashi, S. T. Morita, K. Nakamura, et al.
Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome
J. Am. Coll. Cardiol., October 16, 2002; 40(8): 1437 - 1444.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Shimizu and O. A. Centurion
Electrophysiological properties of the human atrium in atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 302 - 314.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. J.J.M. Brundel, R. H. Henning, H. H. Kampinga, I. C. Van Gelder, and H. J.G.M. Crijns
Molecular mechanisms of remodeling in human atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 315 - 324.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. J.J.M Brundel, J. Ausma, I. C van Gelder, J. J.L Van Der Want, W. H van Gilst, H. J.G.M Crijns, and R. H Henning
Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 380 - 389.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S.P Fynn, D.M Todd, W.J.C Hobbs, K.L Armstrong, and C.J Garratt
Role of dispersion of atrial refractoriness in the recurrence of clinical atrial fibrillation. A manifestation of atrial electrical remodelling in humans?
Eur. Heart J., October 1, 2001; 22(19): 1822 - 1834.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
H. Ramanna, A. Elvan, F. H. M. Wittkampf, J. M. T. de Bakker, R. N. W. Hauer, and E. O. Robles de Medina
Increased dispersion and shortened refractoriness caused by verapamil in chronic atrial fibrillation
J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1403 - 1407.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
Z. Li, E. Hertervig, S. Yuan, Y. Yang, Z. Lin, and S. B. Olsson
Dispersion of atrial repolarization in patients with paroxysmal atrial fibrillation
Europace, January 1, 2001; 3(4): 285 - 291.
[Abstract] [PDF]